Business Wire

License agreement provides IRBM access to CRISPR gene editing technology to be applied across its drug discovery services offering

DUBLIN & ROME--(BUSINESS WIRE)-- ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and IRBM, a leader in the field of drug discovery, today announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants IRBM access to ERS’ CRISPR/Cas9 patent portfolio.

IRBM is a drug discovery CRO with expertise... (continue reading...)

• Fluidra’s Board of Directors appoints Jaime Ramirez as CEO, following a comprehensive succession planning process
• The appointment comes at an appropriate moment to lead the group’s next phase of development and expansion
• Bruce Brooks, current CEO, to remain as Non-Executive Director

BARCELONA, Spain--(BUSINESS WIRE)-- Fluidra, the global leader in equipment and connected solutions in the pool and wellness sector, appoints Jaime Ramirez as the... (continue reading...)

Research from RWS indicates that enterprises are increasingly recognizing the benefits of localized training for global audiences

CHALFONT ST PETER, England--(BUSINESS WIRE)-- Research from RWS suggests that learning and development (L&D) professionals are increasingly aware of the benefits of localizing their training content, with almost three-quarters (73%) of global enterprises now translating content for employees. Encouragingly, half (50%) expect to... (continue reading...)

• Dexcom ONE+ is now available in the UK, incorporating 25 years of Dexcom research to offer a sensor that better meets the needs of those living with diabetes.
• Dexcom’s first-ever State of Type 2 Report features survey findings from people with Type 2 diabetes and reveals majority of respondents struggle with anxiety and depression1.
• The ‘Dexcom State of Type 2 Report’ also shows 54% of people wish they could gain more confidence in managing their Type 2... (continue reading...)

Partnership to fuel growth in the business providing intelligent sensors, hardware and software systems for complex industrial and medical applications

BOSTON--(BUSINESS WIRE)-- Battery Ventures, a global, technology-focused investment firm, today announced it has agreed to acquire steute Technologies GmbH & Co. KG, a company with over 60 years of experience in manufacturing innovative technology solutions for the medical and industrial sectors.

Based in... (continue reading...)